Salarius Pharmaceuticals Inc. buy melinda
Start price
15.04.17
/
50%
€49,892
Target price
27.04.17
€57,784
Performance (%)
9.04%
End price
27.04.17
€54,402
Summary
This prediction ended on 27.04.17 with a price of €54,402. The BUY prediction by melinda finished with a performance of 9.04%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0.300% | 4.701% | 4.537% | 51.554% |
| iShares Nasdaq 100 | 0.434% | 12.255% | 31.983% | 98.287% |
| iShares Nikkei 225® | 1.633% | 12.616% | 43.258% | 69.873% |
| iShares S&P 500 | 0.566% | 7.786% | 23.475% | 69.791% |
Comments by melinda for this prediction
In the thread Flex Pharma Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
hat $
(Vom Mitglied beendet)
Stopped prediction by melinda for Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€51,442
12.06.17
12.06.17
€57,784
21.06.17
21.06.17
14.25%
21.06.17
21.06.17


